Hikma Pharmaceutical | HIK - Ebit


Hikma Pharmaceutical reported $348M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Almirall EUR 71.55M 41.32M Jun/2026
argenx SE USD 486M 7M Sep/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
Autolus Therapeutics Ltd USD -59.51M 12.95M Mar/2026
Bayer EUR 755M 2.77B Jun/2026
Fresenius EUR 719M 118M Jun/2026
Genmab DKK 407M 221M Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 428M 179M Jun/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lakefront Biotherapeutics EUR -43.51M 20.19M Jun/2026
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.1B 51M Jun/2026
Orion EUR 209.9M 33.3M Sep/2026
Recordati EUR 185.16M 45.95M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 1.12B 811M Jun/2026
UCB EUR 1.29B 571M Dec/2025